License U of T Technologies

Who is this for?

Industry and other parties interested in licensing or otherwise using University of Toronto (U of T) technologies or working with spinoff companies based on U of T intellectual property.

What do I need before I can begin?

No information is required to begin. If you have questions regarding licensing University of Toronto (U of T) technologies or working with our spinoff companies, please reach out to the Innovations & Partnerships Office: Director, Innovations at 416-946-5515.

Technology Licensing & Startup Opportunities

The University of Toronto (U of T) is a global leader in turning research into products, services, companies and jobs. The Innovations & Partnerships Office (IPO) is your one-stop-shop to license these technologies or work with spinoff companies based on U of T intellectual property (IP). IPO’s team of technology transfer professionals make the process as quick and easy as possible.

Use the Technology Explorer below to discover market-ready innovations and companies based on U of T IP or contact us to find custom solutions.

Deep Tech Download Newsletter

In the last 5 years, companies emerging from U of T Research have secured more than $1.5 billion in investment and capital. We're #1 in Canada for research-based startups and our ecosystem is among the top 10 university-managed incubators in the world.

Sign up for Deep Tech Download, our quarterly newsletter that features active investment opportunities and the latest on these research-based companies.

Technology Explorer

Technology Keywords
Biomarkers for Diagnosis and Prognosis of Heart Failure heart failure , Biomarkers , SFRP-3 , Slim-1 , Mimecan , IGFBP-7 , Nogo-C , Diagnosis , Prognosis , Cardiomyopathy , Blood , Serum , Plasma , Circulation , Troponin , Natriuretic peptide , Proteins , Marker 
A Small Molecule Allosteric Modulator of CB1R for Treatment of Psychosis and Schizophrenia Neurological Disorders , Brain , cannabinoid , Receptor , CB1R , dopamine , psychosis , schizophrenia , Drug , Drug Discovery , neurotransmitter , neuron , agonist , allosteric modulator , modulator , inhibitor 
Adaptive Neural Implant for Modulation and Observation (ANIMO) Advanced Health Technologies , Wearable Tech , Machine Learning , Battery , Electrical and Computer Engineering , Circuit design , Medical Implants and Prosthetics , Medical Devices 
iTest: A modular cloud platform for industrial motor testing Software , Computer Hardware , Motor , Robotics , Automotive 
Monte Carlo Lights: A model-based reinforcement learning approach to Adaptive Traffic Signal Control Machine Learning , Automotive , Deep Learning , Software , Traffic 
ServiceMiner: Transforming process data into actionable insights Data Analytics , Software , Machine Learning 
Microfluidic Platform for Uniform Spheroid Growth, Release, and Drug Screening Cancer , High-throughput , Screening , Assay , Cell , Extracellular matrix , Collagen , Hydrogel , Microfluidics , Matrix , Organoid , Spheroid , Drug , Drug Discovery 
Point-of-Care Detection of Infectious Disease Using Restriction-Enzyme-Based Reporters Cell Free , Infectious Diseases , Sensors & Instrumentation , Electrochemical Detection , Enzyme , Point-of-Care , POC , mRNA , RNA , Electrode , Microelectrodes , Agriculture , Virus , Bacteria , Bacterial detection , Gene , Circuit 
pH-Responsive Colloids for Enhanced Drug Delivery Drug Delivery , Drug , Colloids , Endocytosis , Transferrin , Receptor , Cancer , Oncology , Small Molecules , Triggered release , Drug Delivery System , Cytotoxicity , Excipients , Lysosomal , Payload , Membrane 
A Drug Delivery Method to Increase Delivery of Nanoparticles to Cancer Tumours Nanoparticle , Nanomaterials and Nanoparticles , Drug Delivery , Cancer , Oncology , Doxorubicin , Liposome , Nanomedicine , Cell 

VPRI Role

  • Market U of T technologies to industry
  • Support the development of startup companies
  • Negotiate license agreements with interested companies
  • Assist in finding partners and funding to support proof-of-concept and commercialization
  • Support long-term relationships with strategic partners that help develop early-stage discoveries into market-ready technologies and products

VPRI Contact

Staff

Jennifer Fraser

Director, Innovations
Innovations & Partnerships Office (IPO)
(416) 946-5515